<?xml version="1.0" encoding="UTF-8"?>
<p>The study of Chang et al. confirmed that some phytochemical compounds, such as berberine, an isoquinoline alkaloid, and its derivatives, can also be considered as therapeutic agents for non-small cell lung cancer for their ability to affect cell cycle regulation, thereby causing growth inhibition and tumorigenesis suppression [
 <xref rid="B5-ijms-22-02991" ref-type="bibr">5</xref>].
</p>
